Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in Tpl2−/− MiceLaura R. Purkey(American University), Kathleen DeCicco-Skinner(American University)CancersOctober 18, 202510.3390/cancers17203362Cited by 0SaveCiteExport RISWatch citationsRelated PapersInhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancer|Oncogenesis|2019|33Unlocking Drug Resistance in Multiple Myeloma: Adipocytes as Modulators of Treatment Response|Cancers|2023|8Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes|PLoS ONE|2022|1